Heptares Enters a New Research and Drug Discovery Collaboration Under its "Orbit" Initiative With New York University School of Medicine

LONDON and NEW YORK, June 28, 2017 /PRNewswire/ --New programme focused onkey GPCR target implicated inaggressivebrain cancerHeptares Therapeutics ("Heptares"), the wholly-owned subsidiary of Sosei Group Corporation (TSE Mothers Index: 4565), announces the launch of a new...